Melissa R. Gertler AssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail424-288-5314 Professional Biography Melissa Gertler is an associate in the Corporate Practice Group in the firm's Century City office. More Legal and Business Bylines From Melissa R. Gertler Elijah E. Cummins Lower Drug Costs Now Act: The Long and Winding Road to Drug Pricing Reform - (Posted On Wednesday, September 22, 2021) The Infrastructure Investment and Jobs Act: Potential Impact on Healthcare Policy and Spending - (Posted On Tuesday, August 24, 2021) Biden’s American Rescue Plan Follows Trend Toward Outpatient Setting, Increase in ASC Investment - (Posted On Thursday, May 20, 2021) Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service - (Posted On Monday, January 11, 2021) CMS Announces New Geographic Direct Contracting Model: Letters of Interest Due by December 21, 2020 - (Posted On Tuesday, December 08, 2020) Eleventh Hour Rulemaking: HHS Eliminates Safe Harbor Protections for PBM Drug Rebates; and Creates Two New Safe Harbors for Point-of-Service Discounts and PBM Fixed-Fee Arrangements - (Posted On Wednesday, December 02, 2020) Texas v. California: SCOTUS Hears Oral Arguments About the Constitutionality of the ACA - (Posted On Tuesday, November 17, 2020) Primary Care First: CMS’s New Value-Based Approach to Primary Care - (Posted On Wednesday, November 11, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) President Trump’s Executive Order Mandating the Purchase of U.S. Drugs Evokes Criticism - (Posted On Wednesday, August 19, 2020) Pagination Page 1 Next page Next › Current Legal Analysis Get the F*** Off My Site! Court Upholds Verbal Contract Termination by: John Mark Goodman Differing Approaches to Earned Wage Access Programs Lead to Regulatory Conflict by: Susan Gross Sholinsky Jury Sides with Penn State in Vintage Trademark Case by: Sara M. Bauer The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know by: Stephanie Trunk , Shoshana Golden Balancing the Scales: How to Use “Legitimate Interest” to Process Personal Data “Fairly” by: Charles-Albert Helleputte , Claire Murphy Senate Judiciary Subcommittee Holds Back Two Key Patent Reform Bills by: Christopher M. Bruno Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Print